Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Orbimed Capital Gp Viii Llc
Over the trailing 90 days, Orbimed Capital Gp Viii Llc (Director at Sionna Therapeutics, Inc.) traded $37.5M of stock (net selling $7.5M) across 2 companies, per 9 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 9 transactions · CIK 1845804
- Net activity
- −$7.5M ($15.0M bought · $22.5M sold)
By Company (Trailing 90 Days)
Transactions (9)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-27 | SCTX | Sell | 2.1M | $0 | Conversion of derivative security |
| 2026-07-27 | SCTX | Buy | 1.0M | $15.0M | Open market or private purchase |
| 2026-07-27 | SCTX | Buy | 348.8K | $0 | Conversion of derivative security |
| 2026-07-07 | SION | Sell | 85.9K | $3.9M | Open market or private sale |
| 2026-06-30 | SION | Sell | 115.8K | $5.3M | Open market or private sale |
| 2026-05-27 | SION | Sell | 101 | $4K | Open market or private sale |
| 2026-05-11 | SION | Sell | 184.6K | $8.5M | Open market or private sale |
| 2026-05-08 | SION | Sell | 59.8K | $2.7M | Open market or private sale |
| 2026-05-07 | SION | Sell | 48.5K | $2.2M | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Orbimed's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.